Effects of Ojeoksangamibang Extract on the Recovery of Liver Function in $CCl_4$-exposed Rats

오적산가미방(五積散加味方) 추출물이 $CCl_4$ 중독 Rat의 간기능 회복에 미치는 영향

  • Lee, Soo-Yeon ;
  • Park, Won-Hyung ;
  • Cha, Yun-Yeop ;
  • Lee, Eun
  • 이수연 ;
  • 박원형 ;
  • 차윤엽 ;
  • 이은
  • Published : 2013.07.31

Abstract

Objectives The objective of present study was to investigate the effect of Ojeoksangamibang ($W\check{u}j\bar{i}s\check{a}nji\bar{a}w\grave{e}if\bar{a}ng$) extract on recovery of liver function in carbontetrachloride ($CCl_4$)-exposed rat. Methods Male rats weighing $230{\pm}7.21g$ fed experimental diet for 1 week and 28 rats were divided into 4 groups. Each of 7 rats was devided into a control group and experimental groups. We fed a control group of rats a basal diet and administered normal saline (100 mg/kg, 1 time/1 day) for 3 weeks. And we fed each experimental group of rats basal diet and administered an extract of Ojeoksangamibang extracts (100 mg/kg, 200 mg/kg, 300 mg/kg, 1 time/1 day) for 3 weeks. We measured lipid of plasma and liver, concentration of proinflammatory cytokines ($IL-1{\beta}$, IL-6 and IL-10). Statistical analysis was done by one-way analysis of variance (ANOVA) and Duncan's multiple range test with significance level at p<0.05. Results Plasma a-fetoprotein (AFP) and total protein concentration showed a tendency to decrease in Ojeoksangamibang extract-treated groups. However, plasma albumin concentration showed no significant differences in all treatment groups. Activity of plasma Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) in the Ojeoksangamibang extract-treated groups, increased addition amount of Ojeoksangamibang extracts tended to decline. Alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and ${\gamma}$-glutamyl transferase (${\gamma}$-GT) activities showed a tendency to decrease in Ojeoksangamibang extract-treated groups, increased addition amount of Ojeoksangamibang extracts tended to decline. Concentration of plasma triglyceride and total cholesterol showed a lower value than that of control group. The liver $IL-1{\beta}$, IL-6 and $TNF-{\alpha}$ concentration were decreased, and IL-10 was increased in Ojeoksangamibang extract groups, compared to control group. Plasma $IL-1{\beta}$, IL-6 and $TNF-{\alpha}$ concentration were decreased, and IL-10 was increased in Ojeoksangamibang extract groups, compared to control group. Conclusions This study suggested that Ojeoksangamibang may alleviate liver inflammatory reaction induced by liver toxicity.

Keywords

Ojeoksangamibang extract;Liver function;A-fetoprotein;AST;ALT;Cytokines

References

  1. Rabson A, Roitt IM, Delves PJ. Really essential medical immunology. Oxford:Blackwell Publishing Ltd. 2005:1-14.
  2. Lee JC, Lee E, Lee YC, Oh H, Yoon HS, Ha TK, Hong EH. Effects of Fructus Foeniculi extract on recovering liver function. Korean J Herbology. 2007;22(4):213-18.
  3. 백상철. 말초성 안면마비 환자군의 한약복용이 간기능에 미치는 영향. 원광대학교 석사학위논문. 2011.
  4. 陳師文. 太平惠民和劑局方. 서울:경희대학교 출판국. 2006:27-8.
  5. 전미혜, 백승희, 신상우, 이영선. 五積散이 자궁근종세포의 사멸과 Cell Apoptosis에 미치는 영향. 대한한방부인과학회지. 2003;16(2):45-55.
  6. 한대희, 이학인. 五積散 전탕액이 해열 및 진통에 미치는 영향. 대한한의학회지. 1984;5(1):72-86.
  7. 박종기, 채우석. 五積散 엑기스 과립의 경구투여와 수침이 동통에 미치는 영향. 대한침구학회지. 1992;9(1):273-91.
  8. 문영희, 박영준. 五積散의 소염 진통효과에 관한 연구. 생약학회지. 1994;25(3):258-63.
  9. 손숙영, 조동현, 두호경. 가미소창음자, 가미오적산 및 가미보중익기탕이 Gentamicin Sulfate로 유발된 白鼠腎損傷에 미치는 영향. 경희한의대논문집. 1990;13:27-59.
  10. 정용재. 간경화 암 나으려면 바보가 되세요. 서울:건강다이제스트사. 2004:256.
  11. 신규원, 이선동, 박해모, 전성진, 변진석. 다용 한약처방 투여가 흰쥐의 신장기능에 미치는 영향. 대한예방한의학회지. 2005;9(1):119-33.
  12. 김승조, 김병각, 오도연, 손의섭. 암 어떻게 치료할 것인가. 서울:건강신문사. 2003:19.
  13. 이삼열. 임상병리해석법. 서울:연세대학교출판부. 1991:61-3.
  14. Kim KS, Park JH. Effect of Artemisia iwayomomi water extract on hepatic injury by carbon tetrachloride in rats II, Effect on serum ALP, LAP activities, total protein, bilirubin content and liver lycogen content. Kor J Res. 1992;32(3):357-64.
  15. Berg B, Johansson BG. Effects on parameters of liver function, plasma lipid oncentration and lipoprotein patterns. Acta Medica Scandinavica. 1973;194(552):13-8.
  16. DeCarli LM, Lieber CS. Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet. J Nutr. 1967;91(3):331-6.
  17. Lieber CS. Biochemical and molecular basis of alcohol induced injury to liver and other tissues. N Eng J Med. 1988;319(25):1639-50. https://doi.org/10.1056/NEJM198812223192505
  18. Lieber CS, DeCarli LM. An experimental model of alcohol feeding and liver injury in the baboon. J Med Prim. 1974;3(3):153-63. https://doi.org/10.1159/000459999
  19. Kim SW, Kim HW, Cho SI, Yun YC. Effects of Sayeoksanhap-pyeongweisan-Gamibang(SPG) on Hepatological Changes in Animals Damared by CCl4. The Journal of Korean Acupuncure & Moxibustion Society. 2007;24(4):197-207.
  20. 고려의학 출판부. 간, 담도 질환. 서울:고려의학. 1989:27.
  21. Jeong TC, Kim HJ, Park JI, Ha CS, Park JD, Kim SI, Roh JK. Protective effects of red gineng saponins against carbon tetrachloride-induced hepatotoxicity in Sprague dawley rats. Planta Medica. 1997;63:136-40. https://doi.org/10.1055/s-2006-957630
  22. Mezey E. Alcoholic liver disease: roles of alcohol and malnutrition. Am J Clin Nutr. 1980;33(12):2709-81.
  23. Jung ME, Jung CK. Ham SS, Nam SM, Kang IJ, Kim SJ. Biochemical and histological effects of Phellinus inteus methanol extract on liver lipid metabolism of rats CCl4 and high fat. J Korean Soc Food SCI Nutr. 2001;30:331-7.
  24. Sipes IG, McQueen CA, Gandolifi AJ, McCuskey RS, Earnest DL. Hepatic and gastrointestinal toxicology. In comprehensive Toxicology. Didcot:Pergamon. 1997:251-71.
  25. Simko V, Connell AM, Banks B. Nutritional status in alcoholics without liver disease. Amer J Clin Nutr. 1982;35(2):197-203.
  26. Kim SY, Kim HP, Lee MK, Byun SJ, Kim SH, Han HM, Moon A, Huh M, Kim YC. The effect of betaine on the CCl4-induced hepatoxicity in rats. Yakhak Hoeji. 1993;37:538-43.
  27. 권미진, 남택정. 매생이가 사염화탄소로 유발된 흰쥐의 간손상에 미치는 영향. 생명과학회지. 2006;16(5):734-9.
  28. Amdur MO, Doull J, Klaassen CD. Toxicology. 4th ed. New York:Pergamon Press. 1991:338.
  29. Hayes AW. Principles and methods of toxicology. New York:Raben Press. 1982:407-45.
  30. Kim DH, Yoon SH. Hepatoprotective Effect of Sosihotang on CCl4 induced Liver Injury in Rats. J Korean Soc. Hygienic Sciences. 1998;4(2):1-6.
  31. Hamada E, Nishida T, Uchiyama Y, Nakamura J, Isahara K, Kazuo H, Huang TP, Momoi T, Ito T, Matsuda H. Activation of Kupffer cell and caspases-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatol. 1999;30(5):807-18. https://doi.org/10.1016/S0168-8278(99)80133-0
  32. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology. 1993;18(3):576-80. https://doi.org/10.1002/hep.1840180316
  33. Simpson KJ, Lukacs NW, Colletti L, Strieter RM, Kunkel SL. Cytokines and the liver. J Hepatol. 1997;27(6):1120-32. https://doi.org/10.1016/S0168-8278(97)80160-2
  34. Huang YS, Chan CY, Wu JC, Pai CH, Chao Y, Lee SD. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol. 1996;24:377-84. https://doi.org/10.1016/S0168-8278(96)80156-5
  35. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R. Circulating and tissue levels of neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis and tissue levels correlate with neutrophil infiltration. Hepatology. 1993;18(1):41-6.
  36. Louis H, Le Moine O, Peny MO, Quertinmont E, Fokan D, Goldman M, Deviere J. Production and role of interleukin-10 in concanavalin A- induced hepatitis in mice. Hepatology. 1997;25(6):1382-9. https://doi.org/10.1002/hep.510250614
  37. Thompson KC, Trowern A, Fowell A, Marathe M, Haycock C, Arthur MJ, Sheron N. Primary rat and mouse hepatic stellate cells express the macrophage. inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology. 1998;28(6):1518-24. https://doi.org/10.1002/hep.510280611
  38. Pender SL, Breese EJ, Günther U, Howie D, Wathen NC, Schuppan D, MacDonald TT. Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases. Gastroenterology. 1998;115(3):573-83. https://doi.org/10.1016/S0016-5085(98)70136-2
  39. Delgado AV, McManus AT, Chambers JP. Production of tumor necrosis factor-alpha, interleukin1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides. 2003;37(6):355-61. https://doi.org/10.1016/j.npep.2003.09.005
  40. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253-78. https://doi.org/10.1146/annurev.iy.08.040190.001345
  41. Mathiak G, Grass G, Herzmann T, Luebke T, Zetina CC, Boehm SA, Bohlen H, Neville LF, Hoelscher AH. Caspase-1-inhibitor ac-YVAD-cmk reduces LPS-lethality in rats without affecting haematology or cytokine responses. Br J Pharmacol. 2000;131(3):383-6. https://doi.org/10.1038/sj.bjp.0703629
  42. Hibi M, Nakajima K, Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med. 1996;74(1):1-12. https://doi.org/10.1007/BF00202068
  43. Hirano T, Matsuda T, Nakajima K. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells. 1994;12(3):262-77. https://doi.org/10.1002/stem.5530120303
  44. Chamulitrat W, Blazka ME, Jordan SJ, Luster MI, Mason RP. Tumor necrosis factor-${\alpha}$ and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci. 1995;57(24):2273-80. https://doi.org/10.1016/0024-3205(95)02220-D
  45. Harbrecht BG, Di Silvio M, Demetris AJ, Simmons RL, Billiar TR. Tumor necrosis factor-a regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatol. 1994;20:1055-60. https://doi.org/10.1002/hep.1840200439
  46. Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 1991;266(12):7313-6.
  47. Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: Stratrgies to restrain this proinflammatory cytokine. Immunol Today. 1997;18(10):487-92. https://doi.org/10.1016/S0167-5699(97)01118-3
  48. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 6th ed. Philadelphia:Elsevier saunders. 2007:354.
  49. Schotte H, Schlüter B, Willeke P, Mickholz E, Schorat MA, Domschke W, Gaubitz M. Long-term treatment with etanercept significantly reduces the number of pro-inflammatory cytokine secteting peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology. 2004;43(8):960-4. https://doi.org/10.1093/rheumatology/keh178
  50. Clerici M, Ferrario E, Trabattoni D, Viviani S, Bonfganti V, Vanzon DJ. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease. Eur J Cancer. 1994;30A(10):1464-70.